The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial-Reference-Cited by-同舟云学术

The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial

Published:2016-07 Issue:1 Volume:75 Page:126-134
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Brinkhuizen Tjinta,Frencken Kiki J.A.,Nelemans Patty J.,Hoff Marlou L.S.,Kelleners-Smeets Nicole W.J.,zur Hausen Axel,van der Horst Michiel P.J.,Rennspiess Dorit,Winnepenninckx Véronique J.L.,van Steensel Maurice A.M.,Mosterd Klara

Publisher

Elsevier BV

Subject

Dermatology

Reference28 articles.

1. Basal cell carcinoma: histological classification and body-site distribution;Raasch;Br J Dermatol,2006

2. Guidelines for the management of basal cell carcinoma;Telfer;Br J Dermatol,2008

3. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicenter, non-inferiority, randomized controlled trial;Bath-Hextall;Lancet Oncol,2014

4. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomized controlled trial;Arits;Lancet Oncol,2013

5. Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials;Roozeboom;Br J Dermatol,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical and Intralesional Immunotherapy for the Management of Basal Cell Carcinoma;Cancers;2024-06-04

2. Oxadiazole Derivatives of Diclofenac as an Anti-proliferative Agent for B-cell Non-Hodgkin Lymphoma: An In vitro and In Silico Studies;Medicinal Chemistry;2024-05

3. Viscum Album Lipophilic Extract in Actinic Keratosis, Cutaneous Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Retrospective Case Series;Complementary Medicine Research;2024

4. NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AS REPURPOSED ANTICANCER DRUGS IN SKIN CANCER;FARMACIA;2024

5. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects;European Journal of Medical Research;2023-09-14